Liberty Leaf Holdings Ltd. (CSE: LIB) (OTCQB: LIBFF) (FSE: HN3P) president and CEO Will Rascan this morning announced that the company’s wholly-owned subsidiary, North Road Ventures, has signed an agreement with Cannabis Compliance Inc. (“CCI”). Per the terms of the agreement, CCI will be responsible for assuring the Good Manufacturing Practice (“GMP”)-compliant processing and production of North Road’s products containing cannabis. GMP requirements ensure that the products manufactured are safe and of consistently high quality for their intended use. “This opens the door for North Road to obtain industry certification and regulatory authorization and/or licensing, as needed. It facilitates the manufacture and sale of a wide range of medicinal-quality products for both human and veterinary use – not just cannabis and cannabis-containing finished products,” Robert Jackman, scientific project manager/fulfillment, stated in the news release.
To view the full press release, visit http://cnw.fm/pN9AM
About Liberty Leaf
Liberty Leaf Holdings Ltd. is a new Canadian-based, public company whose focus is to build and support a diversified portfolio of cannabis-sector businesses, including cultivation, processing, value-added CBD/THC pet products and supply-chain products within this dynamic and fast-growing sector. Liberty Leaf owns a 60% interest in Just Kush, along with 100% wholly-owned North Road Ventures, are both late-stage applicants under Health Canada’s ACMPR. For more information, visit the company’s website at www.LibLeaf.ca.
More from CannabisNewsBreaks
CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.
For more information please visit https://www.cannabisnewswire.com